Group 1 - The stock price of Renmin Tongtai dropped by 2.00% on November 26, trading at 11.74 CNY per share, with a total market capitalization of 6.808 billion CNY [1] - Year-to-date, Renmin Tongtai's stock price has increased by 56.53%, but it has seen a decline of 26.39% over the last five trading days [1] - The company has appeared on the "Dragon and Tiger List" 13 times this year, with the most recent appearance on November 21, where it recorded a net buy of -7.5568 million CNY [1] Group 2 - Renmin Tongtai Pharmaceutical Co., Ltd. was established on February 19, 1994, and is primarily engaged in pharmaceutical wholesale, retail, and medical services [2] - The company's revenue composition includes 57.72% from wholesale to medical clients, 22.26% from wholesale to commercial clients, and 18.91% from retail [2] - As of September 30, the number of shareholders increased to 27,700, with an average of 20,900 circulating shares per shareholder [2] Group 3 - Renmin Tongtai has distributed a total of 1.671 billion CNY in dividends since its A-share listing, with 83.504 million CNY distributed in the last three years [3]
人民同泰跌2.00%,成交额1.56亿元,主力资金净流出71.52万元